US FDA recommends healthcare providers switch from Getinge's heart devices
May 8 (Reuters) - The U.S Food and Drug Administration on Wednesday recommended healthcare facilities transition away from using Getinge's GETIb.ST heart devices as they continued to have safety and quality concerns. (Reporting by Sriparna Roy in Bengaluru; Editing by Shailesh Kuber) ((Sriparna.Roy@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsBrief: CEO Buys SEK 4.7 Million Of Getinge Shares
Johnson & Johnson defeats heart-pump patent claims in US trial (updated)
Johnson & Johnson defeats heart-pump patent claims in US trial
Brief: Getinge's Subsidiary Maquet Cardiovascular Receives Adverse Jury Trial Verdict In Patent Infringement Dispute With Abiomed In U.S.
Getinge lags profit estimates as uncertainty curbs investments in medical equipment